Hypha Labs, Inc. FUNI
$0.01
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -82.09% | -32.11% | -63.61% | -3.94% | -12.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -82.09% | -32.11% | -63.61% | -3.94% | -12.65% |
| Operating Income | 82.09% | 32.11% | 63.61% | 3.94% | 12.65% |
| Income Before Tax | 45.77% | 18.81% | 61.06% | -16.87% | 22.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.77% | 18.81% | 61.06% | -19.83% | 20.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.77% | 18.81% | 61.06% | -19.83% | 20.50% |
| EBIT | 82.09% | 32.11% | 63.61% | 3.94% | 12.65% |
| EBITDA | 82.66% | 32.50% | 63.72% | 4.42% | 13.33% |
| EPS Basic | 53.66% | 32.65% | 68.52% | 2.56% | 37.88% |
| Normalized Basic EPS | 53.85% | 35.48% | 68.66% | 14.81% | 29.73% |
| EPS Diluted | 53.66% | 32.65% | 68.52% | 2.56% | 59.00% |
| Normalized Diluted EPS | 53.85% | 35.48% | 68.66% | 14.81% | 29.73% |
| Average Basic Shares Outstanding | 19.67% | 21.64% | 21.74% | 24.92% | 27.12% |
| Average Diluted Shares Outstanding | 19.67% | 21.64% | 21.74% | 24.92% | 27.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |